Showing posts with label pharma. Show all posts
Showing posts with label pharma. Show all posts

Tuesday, September 3, 2013

Job Post: Global Patient Safety Medical Advisor

Job Post: Global Patient Safety (GPS) Medical Fellow/Advisor

Responsibilities

The purpose of the GPS Medical Fellow/Senior Medical Advisor/ Medical Advisor is to perform medical roles within the Global Patient Safety (GPS) Medical function. These include performing as the Product or Molecule Safety Lead Physician, demonstrating Global Patient Safety expertise and coaching. He or she is the Eli Lilly & Co. GPS Medical Area representative for both internal and external customers regarding a product or molecule, interacting as prescribed in corporate guidelines, standards and policies. Individualized responsibilities for a particular product or project will be discussed and agreed at an individual level.

Key Responsibilities

1. Product or Molecule Safety Physician / Lead Physician

• Provide global medical leadership and input into all aspects of safety of assigned product(s) including surveillance programs and risk management planning.
• Ensure proactive safety surveillance
o i. lead risk management activities for assigned products globally
• ii. lead and guide the surveillance activities of scientists on the team including signal detection and clarification activities and risk evaluation activities; provide support, training and continued improvement as appropriate
• iii. manage decisions and actions to be taken, including communication to appropriate customers (e.g., Product Teams, Management, Affiliates and Regulators) and
• iv. liaise with GPS Medical Area Directors and with Lilly Medical Therapeutic Area Team Leaders and Directors, as appropriate, to fulfill safety obligations;
• Supervise and review reports on safety issues and their implications for the Core Safety Information and Core Risk Minimization Activities, represent PV position to Global Patient Labeling Committee and/or the Safety Review Committee as appropriate.
• Build collaborative working relationships with other Global Patient Safety Physicians and development and brand teams medical globally to ensure full cooperation and high quality medical evaluation of safety data for global regulatory purposes.
o i. Represent GPS Medical and/or Product on appropriate committees/product development and brand teams.
• ii. Provide medical support for Global Patient Safety activities and reports within the department, as appropriate.
• iii. Provide Global Patient Safety expertise to internal customers (e.g., regulatory, early phase development, business units).
• iv. Provide medical input for review of Adverse Event cases.
• v. Lead process and provide medical input for review of Suspected Adverse Reactions
• Demonstrate knowledge in pharmacovigilance and risk minimization, which includes understanding of relevant aspects of laws, regulations and guidance.

Job Post: Oncology Clinical Research Physician

Job Post: Oncology Clinical Research Physician

Responsibilities

The Oncology Clinical Research Physician (CRP) will combine scientific and clinical expertise with his/her passion for helping cancer patients to make meaningful differences to the lives of many people. He/she helps create solutions for patients, health care professionals, and caregivers that have broad impact across the world.

He/She participates in the development, conduct and reporting of local clinical trials; the implementation of global clinical trials ; the reporting of adverse events as mandated by corporate patient safety; review process for protocols, study reports, publications and data dissemination for products; medical outreach, and various medical activities in support of demand realization.

The CRP is an integral member of the Oncology brand team for strategic planning in the support of launch and commercialization activity and may work with Development team(s), Therapeutic Area Program Phase, Early Phase /Exploratory Program Medicine (EPM), and Translational Medicine team(s) in new product development activities over the entire spectrum of drug development and clinical trial phases.

Core Job Responsibilities

The primary responsibilities of the Oncology Medical Affairs CRP are generally related to late-phase and marketed compounds. The CRP is responsible for collaborating with local research staff in the planning, startup and conduct of phase 3b/4 studies. The core job responsibilities include those listed below as well as all other duties as assigned.

Wednesday, August 14, 2013

Job Post: Biostatistician/Director of Biostatistics

Job Post: Biostatistician/Director of Biostatistics for a Contract Research Organization (CRO)

Location: variable

-Client facing
-Experience with FDA submissions – NDA, INDs
-3 plus years of Biostats experience in a pharma/CRO
-experience in Phase I,II, III clinical trials
-experience with CDISC
-PhD preferred

Contact: paul.s.kim@us.ibm.com

Wednesday, May 1, 2013

BioSpace Pharm Country Career Fair

Looking for a job in the biotech or pharmaceutical industry? How about with a contract research organization or CRO?

BioSpace Pharm Country Career Fair
Radisson Valley Forge
Tuesday, May 21, 2013
11am - 4pm

Learn more here.

Monday, March 4, 2013

BIO Career Fair at the 2013 BIO Convention

The BIO Career Fair will be held on Monday, April 22, in conjunction with the 2013 BIO International Convention in Chicago.

BIO Career Fair
Monday, April 22, 2013
Hyatt Regency Chicago
151 E. Wacker Drive

More information can be found here: http://www.biocareerfair.org

Friday, March 1, 2013

2013 BIO International Convention, April 22-25, 2013

Don't miss the 2013 BIO International Convention, April 22-25, 2013
Chicago, IL

This is where science meets business—16,500 attendees from 65 countries, 4 football fields of exhibits, 125+ sessions across 17 topic areas, and biotech’s largest partnering event.

Learn more about this event here:  http://convention.bio.org/

Wednesday, February 27, 2013

BioPharma Asia Convention 2013

Looking for an excuse to visit Asia? How about Singapore?

BioPharma Asia Convention 2013 is the largest and most strategic event in Asia that brings together more than 4,000 key stakeholders and decision makers from all across the globe to explore partnership ideas, business trends and investment opportunities in Asia's biopharma sector.

March 18-21
Singapore

Learn more about this conference here.

Tuesday, February 19, 2013

Saturday, January 5, 2013

Job Posting: Associate Director, Translational Medicine

Associate Director, Translational Medicine
Regeneron - Tarrytown, NY 10591
Job Summary and Essential Functions:
If you are looking for an uncommon opportunity -- a chance to join an organization known for its scientific excellence in the research and development of pharmaceuticals -- it's time to consider Regeneron.

Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use; ZALTRAP is co-commercialized with Sanofi. Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727. Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.

Founded on the principle that strong science would lead to important new medicines, Regeneron has become an integrated biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Regeneron currently markets ARCALYST (rilonacept) Injection for Subcutaneous Use and EYLEA (aflibercept) Injection. Regeneron has therapeutic candidates in Phase 3 clinical trials for the prevention of gout flares, central retinal vein occlusion, diabetic macular edema, certain cancers, and rheumatoid arthritis. Additional therapeutic candidates are in earlier stage development programs in cholesterol reduction, allergic conditions, pain, and cancer.

Wednesday, January 2, 2013

Medical Director jobs in pharma and biotech

Hiring tends to slow down over the holidays, but a number of pharmaceutical and biotechnology companies look to be hiring medical directors. Take a look at some of those pharma and biotech medical director jobs here.

Wednesday, December 26, 2012

CEO of Novartis shares a 30-Second MBA Insight (Fast Company)

Fast Company has an online series of short video segments titled "30 Second MBA"

In this clip, you'll hear Joe Jimenez, the CEO of Novartis share his insights:

Tuesday, October 16, 2012

Pharmaceutical Executive Magazine (Oct 2012)

Do you read the NEJM or JAMA to keep up with the latest evidence-based medicine that you can apply to treat your patients? In the clinical world, we rely on our journals and conferences to stay up-to-date.

In the business world, it's important to keep up with company-related news so that you can understand the trends in the pharmaceutical industry. Pharmaceutical Executive Magazine is one of those resources that can help you stay plugged in with the current issues around pharmaceutical marketing, changes at the FDA, emerging markets, clinical research, and more. You can read the October 2012 issue of Pharmaceutical Executive Magazine here.

Friday, October 12, 2012

MM&M 2012 Career & Salary Survey

Every year, Medical Marketing & Media conducts a salary survey among executives working in the pharmaceutical industry. The 26th MM&M Career & Salary Survey reports average salaries are slightly outpacing inflation, up 2.8% to 132.6K and just below 2007's high of 133.7K.

According to their survey, Medical Directors have an average salary of $176,700 which is up 7.1%. With an n=17 medical directors, this is a relatively small sample.

The online survey was emailed to more than 40,000 executives employed in pharmaceuticals, healthcare marketing and related fields, encompassing manufacturers, agencies, media companies and service suppliers/vendors, during August and September.

Of the 994 qualified respondents: 403 are employed by manufacturers (pharma, biotech, devices, diagnostics), 345 by agencies, 77 work in healthcare media and 88 for suppliers/vendors; 524 are male and 470 are female; and the average age is 43 years.

You can read about the survey here and access the complete report here (PDF).

Wednesday, October 3, 2012

Don't miss this informative webinar about MSLs

eyeforpharma and the MSL Society invite you to this free informative webinar about MSLs titled:

The New MSL/KOL Engagement Paradigm
Innovative KOL relationship models for a brave new world
Wednesday October 10th, 2pm London (BST), 3pm Paris (CET), 9am New York (EST)
Free of charge

Learn about the evolving role of the MSL in today's environment and within increasingly popular Contract Research Organizations.

The speakers for this webinar include:

Dr. Eric Silfen
Chief Medical Officer
Philips Health Care

Dr. Stewart Rosen
Vice President of Medical Affairs
Quintiles

Dr. Samuel Dyer
Chairman of the Board
Medical Science Liaison Society

Learn more and register for this event here.

Monday, September 24, 2012

Medical director jobs in pharmaceutical companies

Interested in a job in pharma? There are many medical director, VP of medical affairs, and to some extent even chief medical officer jobs out there that you can find. You can find these jobs listings by searching here. You'll find jobs posted by small to big pharma and biotech companies.

Find a variety of non-clinical jobs on our Job Board.

Monday, July 2, 2012

Bristol-Myers Squibb acquiring Amylin Pharmaceuticals for $5.3 billion

Amylin Pharmaceuticals makes the diabetes drugs Byetta, Bydureon and Symlin. Bristol-Myers Squibb will own those drugs through its acquisition of Amylin Pharmaceuticals for $5.3 billion. It's complicated because BMS is also going to get paid $3.4 billion by AstraZeneca to develop Amylin’s drug pipeline (because of an AstraZeneca partnership). Amylin ended a marketing partnership on Bydureon and Byetta with Eli Lilly & Co. back in November.  

Friday, May 4, 2012

Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer

NEW YORK, May 2, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the appointment of Gail M. Comer, M. D. as Chief Medical Officer, effective May 14, 2012. In this newly created position, Dr. Comer will report directly to President and Chief Executive Officer, Gary S. Jacob, Ph.D., and will be responsible for guiding Synergy's clinical programs, including the ongoing Phase II/III study of plecanatide, the Company's leading drug candidate.

Dr. Gail Comer, a board-certified gastroenterologist and hepatologist, has more than 14 years of experience in the pharmaceutical industry, having spent 7 years at Abbott Laboratories as a Medical Director, six years in clinical development at Wyeth Research as Senior Medical Director, and most recently as Senior Director of the BioTherapeutics Research Unit at Pfizer. While at Wyeth, Dr. Comer was Medical Research Leader in Gastroenterology, and more recently, while at Pfizer, was Clinical Lead for multiple biologic compounds in early development in inflammatory bowel disease.

Thursday, April 5, 2012

Pharma Thursdays

Pharma Thursdays is a networking group that meets monthly. It grew out of the need for a group in the life science community where people of every level, regardless of company affiliation could get together to exchange ideas, interact, learn and network.

In September of 2008, group founder Ted Gilbert and several other life science professionals saw the need for networking events where people working in all levels of life sciences could get together in Philadelphia. The idea was to gather once a month and exchange ideas, talk about what was going on in the local industry and collect perspectives from people that work in the same industry but carry different skill sets.

They now have over 1,000 members. Chapters are in Princeton, New York City and South Florida. I'm sure we'll see other chapters as well.

Learn more about Pharma Thursdays here.

Friday, March 30, 2012

Young Professionals in Healthcare (YPH) in NJ/PA

If you live in the greater Princeton area, you may want to attend:

Young Professionals in Healthcare (YPH) was founded in 2010 with the mission of bringing together young professionals in a variety of healthcare-related fields. We provide networking, educational, and career opportunities, including happy hours, guest lectures, career and grad school panels, and industry lunches.

Members come from many industries: biotech/pharma, diagnostics, medicine, research, consulting, public health, advertising, and healthcare law.

What's Next for Biopharma - A Discussion with Denise Papiernik

Denise Papiernik, Executive Director and Strategic Product Leader at Bristol Myers-Squibb, will discuss the pharmaceutical industry's response to a wave of recent challenges, including the emergence of biologics, regulatory uncertainty, cost pressures, and loss of exclusivity of key products. Refreshments will be served.

Wednesday, October 26, 2011

The BioCapital Career Fair is Coming Up

Looking for a job in the biopharma industry? A career fair is a good place to find a variety of different opportunities for physicians and scientists interested in working in the biotechnology or pharmaceutical industry.

BioCapital Career Fair
Tuesday, November 1, 2011
11am to 4pm
Bethesda North Marriott & Conference Center
Bethesda, MD

Spend the day speaking with representatives from top biopharmaceutical companies in the area. Face time is hard to get in today's world of technology, so take advantage of this great opportunity to speak with HR reps and hiring managers in person!